Suit targets AbbieVie for alleged kickback scheme

Sept. 19, 2018

Regulators in California are suing AbbieVie for an alleged kickback scheme that boosted prescriptions for its blockbuster medication, Humira.  

According to the suit, the Chicago-based pharma company used “ambassadors,” that it marketed as patient advocates, to convince healthcare professionals to prescribe the treatment.

Humira is the best-selling drug in the world and is prescribed for a range of issues, including Crohn’s Disease and arthritis.

The suit alleges that AbbieVie offered various benefits to doctors who prescribed Humira, including money, meals, travel and other gifts.

AbbieVie has denied the claims and said that it the company does not “interfere” with patient-doctor relations.

Read the full Reuters Report.